Larry F. Lemanski | |
---|---|
Born | Madison, WI | June 5, 1943
Nationality | American |
Alma mater | Arizona State University |
Known for | Novel RNA that Promotes Myofibrillogenesis [1] |
Scientific career | |
Fields | Developmental biology, Stem Cell |
Institutions | Texas A&M University-Commerce |
Doctoral advisor | Eldridge Bertke; Jerry Justus |
Other academic advisors | Lee D. Peachey |
Website | faculty |
Larry F. Lemanski is 'Distinguished Research Professor' and Director of the Biomedical Institute for Regenerative Research (BIRR) at Texas A&M University-Commerce [2] He is also a Regents' Professor of the Texas A & M System, the highest level recognition for Texas A & M System's faculties. [3] He received a B.S. from University of Wisconsin, Platteville and then both M.S. and Ph.D. from Arizona State University, Tempe. He was a postdoctoral fellow at the University of Pennsylvania, Philadelphia and worked there with Prof. Lee D. Peachey. He joined UCSF Medical Center, San Francisco in 1975 as served as an Assistant Professor of Anatomy (1975–1977); he moved to University of Wisconsin, Madison and worked there as Assistant Professor (1977–1979) and Associate Professor (1979–1981). He was appointed as full Professor in 1981. He was Provost and Vice President for Academic Affairs at Texas A&M University-Commerce during 2009–2012. [4]
His main research interests concern a study of myofibrillogenesis and heart inductive processes in developing embryonic hearts at the cell and molecular levels. He has studied cardiac mutant axolotls, transgenic mice, and induced pluripotent adult stem cells. His goals have been to elucidate the sequence of events and mechanism(s) of myofibrillogenesis and to explain how inductive interactions direct heart differentiation at the cellular and gene levels. He is known for discovering unique and specific ribonucleic acids (RNAs) that have the capacity to promote cardiac myofibrillogenesis in non-muscle cells. He is pursuing the mechanism of this exciting and intriguing phenomenon and we are exploring inducing heart muscle repair in hearts damaged from disease processes such as myocardial infarctions (heart attacks).
Cardiac muscle is one of three types of vertebrate muscle tissues, the others being skeletal muscle and smooth muscle. It is an involuntary, striated muscle that constitutes the main tissue of the wall of the heart. The cardiac muscle (myocardium) forms a thick middle layer between the outer layer of the heart wall and the inner layer, with blood supplied via the coronary circulation. It is composed of individual cardiac muscle cells joined by intercalated discs, and encased by collagen fibers and other substances that form the extracellular matrix.
Striated muscle tissue is a muscle tissue that features repeating functional units called sarcomeres. The presence of sarcomeres manifests as a series of bands visible along the muscle fibers, which is responsible for the striated appearance observed in microscopic images of this tissue. There are two types of striated muscle:
The University of Texas Southwestern Medical Center is a public academic health science center in Dallas, Texas. With approximately 23,000 employees, more than 3,000 full-time faculty, and nearly 4 million outpatient visits per year, UT Southwestern is the largest medical school in the University of Texas System and the State of Texas.
Doris Anita Taylor is an American scientist working in regenerative medicine and tissue engineering. She was the Director, Regenerative Medicine Research and Director, Center for Cell and Organ Biotechnology at the Texas Heart Institute in Houston, Texas until March 2020. She is the Co-Founder of Miromatrix Medical, Inc. and Co-Founder of Organamet Bio, Inc.
mir-133 is a type of non-coding RNA called a microRNA that was first experimentally characterised in mice. Homologues have since been discovered in several other species including invertebrates such as the fruitfly Drosophila melanogaster. Each species often encodes multiple microRNAs with identical or similar mature sequence. For example, in the human genome there are three known miR-133 genes: miR-133a-1, miR-133a-2 and miR-133b found on chromosomes 18, 20 and 6 respectively. The mature sequence is excised from the 3' arm of the hairpin. miR-133 is expressed in muscle tissue and appears to repress the expression of non-muscle genes.
The miR-1 microRNA precursor is a small micro RNA that regulates its target protein's expression in the cell. microRNAs are transcribed as ~70 nucleotide precursors and subsequently processed by the Dicer enzyme to give products at ~22 nucleotides. In this case the mature sequence comes from the 3' arm of the precursor. The mature products are thought to have regulatory roles through complementarity to mRNA. In humans there are two distinct microRNAs that share an identical mature sequence, and these are called miR-1-1 and miR-1-2.
Gap junction alpha-1 protein (GJA1), also known as connexin 43 (Cx43), is a protein that in humans is encoded by the GJA1 gene on chromosome 6. As a connexin, GJA1 is a component of gap junctions, which allow for gap junction intercellular communication (GJIC) between cells to regulate cell death, proliferation, and differentiation. As a result of its function, GJA1 is implicated in many biological processes, including muscle contraction, embryonic development, inflammation, and spermatogenesis, as well as diseases, including oculodentodigital dysplasia (ODDD), heart malformations, and cancers.
In cardiology neocardiogenesis is the homeostatic regeneration, repair and renewal of sections of malfunctioning adult cardiovascular tissue. This includes a combination of cardiomyogenesis and angiogenesis.
Gerald D. Fischbach is an American neuroscientist. He received his M.D. from the Weill Cornell Medical College of Cornell University in 1965 before beginning his research career at the National Institutes of Health in 1966, where his research focused on the mechanisms of neuromuscular junctions. After his tenure at the National Institutes of Health, Fischbach was a professor at Harvard University Medical School from 1972 to 1981 and from 1990 to 1998 and the Washington University School of Medicine from 1981 to 1990. In 1998, he was named the director of the National Institute of Neurological Disorders and Stroke before becoming the Vice President and Dean of the Health and Biomedical Sciences, the Dean of the Faculty of Medicine, and the Dean of the Faculty of Health Sciences at Columbia University from 2001 to 2006. Gerald Fischbach currently serves as the scientific director overseeing the Simons Foundation Autism Research Initiative. Throughout Fischbach's career, much of his research has focused on the formation and function of the neuromuscular junction, which stemmed from his innovative use of cell culture to study synaptic mechanisms.
Cell potency is a cell's ability to differentiate into other cell types. The more cell types a cell can differentiate into, the greater its potency. Potency is also described as the gene activation potential within a cell, which like a continuum, begins with totipotency to designate a cell with the most differentiation potential, pluripotency, multipotency, oligopotency, and finally unipotency.
A. Hari Reddi is a University of California Distinguished Professor and holder of the Lawrence J. Ellison Endowed Chair in Musculoskeletal Molecular Biology at the University of California, Davis. His research played an indispensable role in the identification, isolation and purification of bone morphogenetic proteins (BMPs) that are involved in bone formation and repair.
John Walter Woodbury (1923–2017) was an American electrophysiologist and author of the first textbook explanation of the Hodgkin-Huxley_model studies of the action potential. He applied physical and mathematical techniques to experimentally elucidate the nature of electrical excitability in cells. He was also involved in the experimental and theoretical investigations of the mechanisms of ion penetration through the ion channels in muscle membranes, the regulation of cellular acid-base balance and the control of epileptic seizures by repetitive Vagus nerve stimulation.
Kenneth D. Poss is an American biologist and currently James B. Duke Professor of Cell Biology and director of the Regeneration Next Initiative at the Duke University School of Medicine.
George "Rick" Stouffer is an American cardiologist who is Chief of the Division of Cardiology at the University of North Carolina Medical Center, where he is a practicing interventional cardiologist. Stouffer was awarded the Ernest and Hazel Craige Distinguished Professorship of Medicine in 2018; prior to that he was the Henry A. Foscue Distinguished Professor of Medicine. Stouffer is also co-director of the McAllister Heart Institute. He is known for his research regarding inpatient ST elevation myocardial infarctions.
Kenneth R. Chien is an American doctor and medical scientist who has been a research director at Karolinska Institute, in Stockholm, since 2013. Chien has several papers with over 1,000 citations and a h-index of 132. His area of expertise is cardiovascular science. His research into regenerative cardiovascular medicine, specifically while director of the Cardiovascular Program of the Harvard Stem Cell Institute, led to his co-founding, in 2010, of ModeRNA Therapeutics. In 2018, the company re-branded as Moderna, Inc. Chien is a recipient of the Walter Bradford Cannon Award of the American Physiology Society and the Pasarow Award. He is a member of the Norwegian Academy of Science and Letters, the Austrian Academy of Sciences, and has received an honorary doctorate from the University of Edinburgh.
Guillermo Oliver is a Uruguayan-American research scientist. He is currently the Thomas D. Spies Professor of Lymphatic Metabolism at Northwestern University, and director of the Center for Vascular and Developmental Biology at the Feinberg Cardiovascular Research Institute. Oliver is an elected member of both the American Association for the Advancement of Science and the Academia de Ciencias de América Latina.
Ying Ge is a Chinese-American chemist who is a Professor of Cell and Regenerative Biology at the University of Wisconsin–Madison. Her research considers the molecular mechanisms that underpin cardiac disease. She has previously served on the board of directors of the American Society for Mass Spectrometry. In 2020 Ge was named on the Analytical Scientist Power List.
Evan Dale Abel is an American endocrinologist who serves as Chair of the Department of Medicine at the David Geffen School of Medicine at UCLA. His works on the molecular mechanisms that underpin cardiac failure in diabetes. He is a Fellow of the American Heart Association and the American College of Physicians. He was elected a member of the National Academy of Sciences in 2022.
Roberta Anne Gottlieb is an American oncologist, academic, and researcher. She is a Professor, and Vice-Chair of Translational Medicine in the Department of Biomedical Sciences at Cedars-Sinai Medical Center, and a Professor of Medicine at the University of California, Los Angeles.
Olga Ornatsky is a Soviet born, Canadian scientist. Ornatsky co-founded DVS Sciences in 2004 along with Dmitry Bandura, Vladimir Baranov and Scott D. Tanner.